Press Releases

Indivior to Announce FY 2021 Results and Host a Presentation on February 16th

Download as PDF

Slough, UK, and Richmond, VA, February 1, 2022 – Indivior PLC (LON: INDV) today announced that it will release its FY 2021 results on February 16th at 7:00 a.m. London time (2:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange’s Regulatory News Service (RNS) and on the “Investors” section of the company’s website at

Mark Crossley, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation  via live webcast at 13:00 GMT (8:00 a.m. U.S. Eastern) on February 16th.

Access to the Live Webcast Presentation

The webcast event and materials can be accessed on the “Investors” section of the company’s website at before the event begins.

The webcast link is:

Participants may access the presentation telephonically:

  • US participants 1-646-741-3167
  • International participants +44 (0) 2071-928338

Please reference confirmation ID 8268632. A replay of the presentation will be available at


About Indivior

Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit to learn more. Connect with Indivior on LinkedIn by visiting



Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or